カテゴリ分類されていないページ

移動: 案内検索

51 件目から100 件目までの範囲内で最大 50 件の結果を表示しています。

(前の50件 | 次の50件) (20 | 50 | 100 | 250 | 500 件) を表示

  1. (Fig. 3f, Supplementary Fig. S4). Less than these situations, PatA, and to
  2. (Fig. 4c). To investigate the part of resveratrol on AMPK, cells
  3. (Fig 1C). Non-specific binding of the antibody was sometimes found in
  4. (Figure 3A). Cells were loaded using the calcium indicator Fura2/AM
  5. (Figure 3a). When proteins are degraded at the post-translational level, there
  6. (GAPs) these types of as 2- and 2-chimaerin, EphA receptor activation sales opportunities to
  7. (KSOM; EMD Millipore, Billerica, MA) supplemented with 0.3 fatty acid free bovine
  8. (Lewen et al., 2000). Our conclusions indicate that Rit-dependent signaling is actually a
  9. (MeT) channels to detect mechanical stimuli delivered by a feather's
  10. (Meiklejohn et al. 2013). Collectively, these mutations disrupt larval metabolism, delay improvement
  11. (Meiklejohn et al. 2013). Together, these mutations disrupt larval metabolism, delay improvement
  12. (NMDG-Glu) answer employed as an external remedy contained (in mM): 120 NMDG
  13. (PDH) metabolism and had been probable cofractionated since in their association with
  14. (Perkin-Elmer LS50B; PerkinElmer Life and Analytical Sciences, Waltham, MA, USA
  15. (Vasseur et al., 2002a). p8 Represses FoxO3 Transactivation of bnip3 p
  16. (Warburton et al., 1986).M.W. Brown et al. / Neuropsychologia 50 (2012) 31224. Item recognition
  17. ( 0.four 12.four 0 four(1a QD would be the quantum yield determined by steady-state fluorescence working with
  18. (a) An ordinary differential equation. (b) Arrows indicate constraints around the
  19. (a) An ordinary differential equation. (b) Arrows indicate constraints on the
  20. (a) the partnership among contact duration and transmission probability, (b) person
  21. (autophagosomes), in parallel having a substantial reduce in pink puncta, confirming
  22. (eighteen). These two strategies, coinfection with adenovirus and knockdown of U2 snRNP
  23. (ii) robust neurodegeneration is present, and (iii) animals haven't nonetheless
  24. (jewelry/jewellery )
  25. (left) and inside the presence of 200 M AITC (right). (B) Summary
  26. (mutant peak is indicated by a grey arrow). The bases are
  27. (n = 15), srt mutant (n = twenty) and srt complemented strains (n = ten). Disease progression
  28. (n = fifteen), srt mutant (n = 20) and srt complemented strains (n = ten). Ailment development
  29. (n = fifteen), srt mutant (n = 20) and srt complemented strains (n = ten). Condition progression
  30. (n = fifteen), srt mutant (n = 20) and srt complemented strains (n = ten). Disease development
  31. (n = fifteen), srt mutant (n = 20) and srt complemented strains (n = ten). Disease progression
  32. (n = fifteen), srt mutant (n = 20) and srt complemented strains (n = ten). Illness progression
  33. (n = fifteen), srt mutant (n = twenty) and srt complemented strains (n = 10). Disorder development
  34. (n = fifteen), srt mutant (n = twenty) and srt complemented strains (n = 10). Sickness development
  35. (n = fifteen), srt mutant (n = twenty) and srt complemented strains (n = ten). Ailment progression
  36. (n = fifteen), srt mutant (n = twenty) and srt complemented strains (n = ten). Disease progression
  37. (pH 5.five, containing 0.five mM EDTA, 2 mM TCEP, and 0.two LPPG). Near-UV and Far-UV
  38. (pH 7.5) buffer that contains 0.twenty five M sucrose, one mM EDTA, 10 mM -mercaptoethanol, 1 mM benzamidine
  39. (rings/engagement rings)
  40. (seven) days and ended up euthanized by CO2 asphyxiation on signs of systemic
  41. (seven) days and ended up euthanized by CO2 asphyxiation upon indicators of systemic
  42. (seven) days and had been euthanized by CO2 asphyxiation upon signals of systemic
  43. (seven) times and ended up euthanized by CO2 asphyxiation on indications of systemic
  44. (seven) times and have been euthanized by CO2 asphyxiation on symptoms of systemic
  45. (seven) times and were being euthanized by CO2 asphyxiation on signs of systemic
  46. (seventeen) and Iraqui et al. (32) have observed similar Ssy1p-dependent expression of
  47. (ten), exactly where an developed AGT variant is exclusively labeled in vivo by
  48. (ten), where an evolved AGT variant is especially labeled in vivo by
  49. (ten), where an evolved AGT variant is particularly labeled in vivo by
  50. (ten), where by an advanced AGT variant is specially labeled in vivo by

(前の50件 | 次の50件) (20 | 50 | 100 | 250 | 500 件) を表示